CEO of Chelsea Therapeutics International Ltd. (CHTP, Financial) Simon Pedder buys 1,250 shares of CHTP on 09/02/2010 at an average price of $4.08 a share.
Chelsea Therapeutics International Ltd. has a market cap of $163.61 million; its shares were traded at around $4.07 .
CHTP is in the portfolios of Jim Simons of Renaissance Technologies LLC.
Chelsea Therapeutics International Ltd. has a market cap of $163.61 million; its shares were traded at around $4.07 .
CHTP is in the portfolios of Jim Simons of Renaissance Technologies LLC.
Directors and Officers Recent Trades:
- Buy: Vice President of Operations Joseph Oliveto bought 3,500 shares of CHTP stock on 08/12/2010 at the average price of 2.87. Joseph Oliveto owns at least 3,500 shares after this. The price of the stock has increased by 41.81% since.
- Buy: VP, Business Development Michael J Roberts bought 2,000 shares of CHTP stock on 08/11/2010 at the average price of 3.1. Michael J Roberts owns at least 22,000 shares after this. The price of the stock has increased by 31.29% since.
- Buy: 10% Owner Josiah T Austin bought 100,000 shares of CHTP stock on 06/09/2010 at the average price of 2.97. Josiah T Austin owns at least 8,190,487 shares after this. The price of the stock has increased by 37.04% since.
- Buy: Director William Dodge Rueckert bought 15,000 shares of CHTP stock on 06/08/2010 at the average price of 3. William Dodge Rueckert owns at least 40,000 shares after this. The price of the stock has increased by 35.67% since.
- Buy: 10% Owner Josiah T Austin bought 10,000 shares of CHTP stock on 06/04/2010 at the average price of 3.19. Josiah T Austin owns at least 8,090,487 shares after this. The price of the stock has increased by 27.59% since.
